Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico

References

• Abadie, R., Welch-Lazoritz, M., Gelpi-Acosta, C., Reyes, J. C., & Dombrowski, K. (2016). Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduction Journal, 13, 10, doi:10.1186/s12954-016-0099-9
   PubMed Web of Science ®Google Scholar
• Aspinall, E. J., Weir, A., Sacks-Davis, R., Spelman, T., Grebely, J., Higgs, P., … Hellard, M. E. (2014). Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. International Journal of Drug Policy, 25(1), 179–182.
   PubMed Web of Science ®Google Scholar
• Brewer, D. D., Hagan, H., Sullivan, D. G., Muth, S. Q., Hough, E. S., Feuerborn, N. A., … Gretch, D. R. (2006). Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. Journal of Infectious Diseases, 194(6), 764–772. doi:10.1086/505585
   PubMed Web of Science ®Google Scholar
• Bruneau, J., Zang, G., Abrahamowicz, M., Jutras-Aswad, D., Daniel, M., & Roy, É. (2014). Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: A longitudinal study. Clinical Infectious Diseases, 58(6), 755–761.
   PubMed Web of Science ®Google Scholar
• CDC. (2010). HIV Surveillance Report 2010. Retrieved April 2, 2013, from http://www.cdc.gov/hiv/surveillance/resources/reports/2010report/
   Google Scholar
• CDC. (2013). Testing for HCV infection: An update of guidance for clinicians and laboratorians. Centers for Disease Control and Prevention.
   Google Scholar
• Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the united states: A retrospective analysis of the past 50 Years. JAMA Psychiatry, 71(7), 821–826. doi:10.1001/jamapsychiatry.2014.366
   PubMed Web of Science ®Google Scholar
• Colón-López, V., Ortiz, A. P., Banerjee, G., Gertz, A. M., & García, H. (2013). HIV and syphilis infection among men attending an sexually transmitted infection clinic in puerto rico. PR Health Sciences Journal, 32(1). Retrieved from http://prhsj.rcm.upr.edu/index.php/prhsj/article/view/657
   Google Scholar
• Coronado-García, M., Thrash, C. R., Welch-Lazoritz, M., Gauthier, R., Reyes, J. C., Khan, B., … Dombrowski, K. (2017). Using network sampling and recruitment data to understand social structures related to community health in a population of people who inject drugs in rural puerto rico. Puerto Rico Health Sciences Journal, 36(2), 77–83.
   PubMed Web of Science ®Google Scholar
• Cox, J., Morissette, C., De, P., Tremblay, C., Allard, R., Graves, L., … Roy, E. (2009). Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users. Substance Use & Misuse, 44(4), 548–568. doi:10.1080/10826080802544349
   PubMed Web of Science ®Google Scholar
• Dombrowski, K., Crawford, D., Khan, B., & Tyler, K. (2016a). Current rural drug use in the US Midwest. Journal of Drug Abuse. Retrieved from http://drugabuse.imedpub.com/abstract/current-rural-drug-use-in-the-us-midwest-11072.html
   Google Scholar
• Dombrowski, K., Curtis, R., Friedman, S., & Khan, B. (2013a). Topological and historical considerations for infectious disease transmission among injecting drug users in Bushwick, Brooklyn (USA). World Journal of AIDS, 3(1), 1–9. doi:10.4236/wja.2013.31001
   Google Scholar
• Dombrowski, K., Khan, B., Habecker, P., Hagan, H., Friedman, S. R., & Saad, M. (2016b). The interaction of risk network structures and virus natural history in the Non-spreading of HIV among people who inject drugs in the early stages of the epidemic. AIDS and Behavior, 1–12. doi:10.1007/s10461-016-1568-6
   Google Scholar
• Dombrowski, K., Khan, B., McLean, K., Curtis, R., Wendel, T., Misshula, E., … Friedman, S. (2013b). A reexamination of connectivity trends via exponential random graph modeling in Two IDU risk networks. Substance Use & Misuse, 48, 1485–1497. doi:10.3109/10826084.2013.796987
   Google Scholar
• Duncan, I., Curtis, R., Reyes, J. C., Abadie, R., Khan, B., & Dombrowski, K. (2017). Hepatitis C serosorting among people who inject drugs in rural Puerto Rico. Preventive Medicine Reports, 6, 38–43. doi:10.1016/j.pmedr.2017.02.001
   PubMedGoogle Scholar
• FDA. (2011). Summary of Safety and Effectiveness Data (SSED): Antibody to Hepatitis C Virus (Anti-HCV) Rapid Assay (No. PMA P080027/S001). Retrieved from http://www.accessdata.fda.gov/cdrh_docs/pdf8/P080027S001b.pdf
   Google Scholar
• Friedman, S. R., Neaigus, A., Jose, B., Curtis, R., Goldstein, M., Ildefonso, G., … Des Jarlais, D. C. (1997). Sociometric risk networks and risk for HIV infection. American Journal of Public Health, 87(8), 1289–1296.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Sandoval, M., Mateu-Gelabert, P., Meylakhs, P., & Jarlais, D. C. D. (2011). Symbiotic goals and the prevention of Blood-borne viruses among injection drug users. Substance Use & Misuse, 46(2,3), 307–315. doi:10.3109/10826084.2011.523316
   PubMed Web of Science ®Google Scholar
• Gile, K. J., & Handcock, M. S. (2010). Respondent-driven sampling: An assessment of current methodology. Sociological Methodology, 40(1), 285–327. doi:10.1111/j.1467-9531.2010.01223.x
   PubMed Web of Science ®Google Scholar
• Hagan, H, Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91(1), 42–46.
   PubMed Web of Science ®Google Scholar
• Hagan, H., Campbell, J., Thiede, H., Strathdee, S., Ouellet, L., Kapadia, F., … Garfein, R. S. (2006). Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Reports, 121(6), 710–719.
   PubMed Web of Science ®Google Scholar
• Hahn, J. A., Evans, J. L., Davidson, P. J., Lum, P. J., & Page, K. (2010). Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction, 105(7), 1254–1264. doi:10.1111/j.1360-0443.2010.02949.x
   PubMed Web of Science ®Google Scholar
• Johnston, L. G., Chen, Y.-H., Silva-Santisteban, A., & Raymond, H. F. (2013). An empirical examination of respondent driven sampling design effects among HIV risk groups from studies conducted around the world. AIDS and Behavior, 17(6), 2202–2210. doi:10.1007/s10461-012-0394-8
   PubMed Web of Science ®Google Scholar
• Khan, B., Dombrowski, K., Saad, M., McLean, K., & Friedman, S. (2013). Network firewall dynamics and the subsaturation stabilization of HIV. Discrete Dynamics in Nature and Society, 2013, 1–16. doi:10.1155/2013/720818
   Web of Science ®Google Scholar
• Kwiatkowski, C. F., Fortuin Corsi, K., & Booth, R. E. (2002). The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97(10), 1289–1294. doi:10.1046/j.1360-0443.2002.00208.x
   PubMed Web of Science ®Google Scholar
• Lansky, A., Finlayson, T., Johnson, C., Holtzman, D., Wejnert, C., Mitsch, A., … Crepaz, N. (2014). Estimating the number of persons who inject drugs in the united states by Meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS ONE, 9(5), 1–9. doi:10.1371/journal.pone.0097596
   Web of Science ®Google Scholar
• Latkin, C., Yang, C., Srikrishnan, A. K., Solomon, S., Mehta, S. H., Celentano, D. D., … Solomon, S. S. (2011). The relationship between social network factors, HIV, and hepatitis C among injection drug users in Chennai, India. Drug and Alcohol Dependence, 117(1), 50–54. doi:10.1016/j.drugalcdep.2011.01.005
   PubMed Web of Science ®Google Scholar
• Long, J. S. (1997). Regression models for categorical and limited dependent variables. Thousand Oaks, CA: SAGE Publications, Inc.
   Google Scholar
• Long, J. S., & Freese, J. (2006). Regression models for categorical dependent variables using stata (Second Edition). College Station, TX: StataCorp LP.
   Google Scholar
• López, L. M., de Saxe Zerden, L., Bourgois, P., Hansen, H., Abadie, R., Dombrowski, K., … Curtis, R. (2015). HIV/AIDS in puerto rican people who inject drugs: Policy considerations. American Journal of Public Health, 105(1), e3–e3.
   PubMed Web of Science ®Google Scholar
• MacArthur, G. J., van Velzen, E., Palmateer, N., Kimber, J., Pharris, A., Hope, V., … Hutchinson, S. J. (2014). Interventions to prevent HIV and hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness. International Journal of Drug Policy, 25(1), 34–52. doi:10.1016/j.drugpo.2013.07.001
   PubMed Web of Science ®Google Scholar
• Mackesy-Amiti, M. E., Ouellet, L. J., Golub, E. T., Hudson, S., Hagan, H., & Garfein, R. S. (2011). Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial. Addiction, 106(3), 601–608. doi:10.1111/j.1360-0443.2010.03251.x
   PubMed Web of Science ®Google Scholar
• Miller, E. R., Hellard, M. E., Bowden, S., Bharadwaj, M., & Aitken, C. K. (2009). Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. Journal of Infection, 58(5), 375–382. doi:10.1016/j.jinf.2009.02.014
   PubMed Web of Science ®Google Scholar
• Miller, M., Mella, I., Moi, H., & Eskild, A. (2003). HIV and hepatitis C virus risk in new and longer-term injecting drug users in oslo, Norway. Journal of Acquired Immune Deficiency Syndromes, 33, 373–379.
   PubMed Web of Science ®Google Scholar
• Neaigus, A., Friedman, S. R., Kottiri, B. J., & Des Jarlais, D. C. (2001). HIV risk networks and HIV transmission among injecting drug users. Evaluation and Program Planning, 24(2), 221–226. doi:10.1016/S0149-7189(01)00012-X
   Web of Science ®Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., … Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. The Lancet, 378(9791), 571–583. doi:10.1016/S0140-6736(11)61097-0
   PubMed Web of Science ®Google Scholar
• Nordén, L., & Lidman, C. (2005). Differentiated risk behaviour for HIV and hepatitis among injecting drug users (IDUs). Scandinavian Journal of Infectious Diseases, 37(6,7), 493–496. doi:10.1080/00365540510036642
   PubMedGoogle Scholar
• Norden, L., Saxon, L., Kåberg, M., Käll, K., Franck, J., & Lidman, C. (2009). Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden. Scandinavian Journal of Infectious Diseases, 41(10), 727–734. doi:10.1080/00365540903159279
   PubMed Web of Science ®Google Scholar
• Norman, L. R., Dévieux, J. G., Rosenberg, R., & Malow, R. M. (2011). HIV-testing practices and a history of substance use among women living in public housing in puerto rico. Journal of the International Association of Physicians in AIDS Care (JIAPAC), 10(4), 260–265. doi:10.1177/1545109710393310
   PubMedGoogle Scholar
• Ompad, D. C., Fuller, C. M., Vlahov, D., Thomas, D., & Strathdee, S. A. (2002). Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in baltimore, Maryland. Clinical Infectious Diseases, 35(7), 783–788. doi:10.1086/342063
   PubMed Web of Science ®Google Scholar
• Paquette, D. M., Bryant, J., & De Wit, J. (2011). Use of respondent-driven sampling to enhance understanding of injecting networks: A study of people who inject drugs in Sydney, Australia. International Journal of Drug Policy, 22(4), 267–273. doi:10.1016/j.drugpo.2011.03.007
   PubMed Web of Science ®Google Scholar
• Pérez, C. M., Marrero, E., Meléndez, M., Adrovet, S., Colón, H., Ortiz, A. P., … Suárez, E. (2010). Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21–64 years in Puerto Rico. BMC Infectious Diseases, 10(1), 76. doi:10.1186/1471-2334-10-76
   PubMedGoogle Scholar
• Perez Torruella, R. A. (2010). ¿Alla en Nueva York todo es mejor?: A qualitative study on the relocation of drug users from Puerto Rico to the United States. City University of New York. Retrieved from http://gradworks.umi.com/33/96/3396474.html
   Google Scholar
• Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., … Duwve, J. M. (2016). HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. New England Journal of Medicine, 375(3), 229–239. doi:10.1056/NEJMoa1515195
   PubMed Web of Science ®Google Scholar
• Pilon, R., Leonard, L., Kim, J., Vallee, D., Rubeis, E. D., Jolly, A. M., … Sandstrom, P. (2011). Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLOS ONE, 6(7), e22245. doi:10.1371/journal.pone.0022245
   PubMed Web of Science ®Google Scholar
• Reyes, J. C., Colón, H. M., Robles, R. R., Rios, E., Matos, T. D., Negrón, J., … Shepard, E. (2006). Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in san juan, puerto rico. Journal of Urban Health, 83(6), 1105–1113. doi:10.1007/s11524-006-9109-7
   PubMed Web of Science ®Google Scholar
• Rhodes, T., & Treloar, C. (2008). The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction, 103(10), 1593–1603. doi:10.1111/j.1360-0443.2008.02306.x
   PubMed Web of Science ®Google Scholar
• Romano, C. M., de Carvalho-Mello, I. M. V. G., Jamal, L. F., de Melo, F. L., Iamarino, A., Motoki, M., … the VGDN Consortium. (2010). Social networks shape the transmission dynamics of hepatitis C virus. PLoS ONE, 5(6), e11170. doi:10.1371/journal.pone.0011170
   PubMed Web of Science ®Google Scholar
• Sacks-Davis, R., Daraganova, G., Aitken, C., Higgs, P., Tracy, L., Bowden, S., … Hellard, M. (2012). Hepatitis C virus phylogenetic clustering is associated with the Social-injecting network in a cohort of people who inject drugs. PLOS ONE, 7(10), e47335. doi:10.1371/journal.pone.0047335
   PubMed Web of Science ®Google Scholar
• Smith, B. D., Jewett, A., Burt, R. D., Zibbell, J. E., Yartel, A. K., & DiNenno, E. (2013). “To Share or Not to Share?” Serosorting by hepatitis C status in the sharing of drug injection equipment Among NHBS-IDU2 Participants. Journal of Infectious Diseases, 208(12), 1934–1942.
   PubMed Web of Science ®Google Scholar
• Smith, D. J., Combellick, J., Jordan, A. E., & Hagan, H. (2015). Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. International Journal of Drug Policy. Retrieved from http://www.sciencedirect.com/science/article/pii/S0955395915002054
   Web of Science ®Google Scholar
• Spelman, T., Morris, M. D., Zang, G., Rice, T., Page, K., Maher, L., … Study), on behalf of the I. C. of I. H. and H. C. in I. C. (InC3. (2015). A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs. Journal of Epidemiology and Community Health, 1–8. doi:10.1136/jech-2014-205224
   Web of Science ®Google Scholar
• Spiller, M. W., Cameron, C., & Heckathorn, D. D. (2012). RDSAT 7.1 user manual: RDS analysis tool 7.1. Cornell University.
   Google Scholar
• Suryaprasad, A. G., White, J. Z., Xu, F., Eichler, B.-A., Hamilton, J., Patel, A., … Holmberg, S. D. (2014). Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 59(10), 1411–1419. doi:10.1093/cid/ciu643
   PubMed Web of Science ®Google Scholar
• Treloar, C., Newland, J., Harris, M., Deacon, R., & Maher, L. (2010). A diagnosis of hepatitis C. Retrieved from http://www.researchgate.net/profile/Lisa_Maher/publication/46579848_A_diagnosis_of_hepatitis_C_-_insights_from_a_study_on_patients'_experiences/links/02e7e51b95b0a69fcc000000.pdf
   Google Scholar
• Vidal-Trécan, G., Coste, J., Varescon-Pousson, I., Christoforov, B., & Boissonnas, A. (2000). HCV status knowledge and risk behaviours amongst intravenous drug users. European Journal of Epidemiology, 16(5), 439–445. doi:10.1023/A:1007622831518
   PubMed Web of Science ®Google Scholar
• Wejnert, C. (2009). An empirical test of Respondent-driven sampling: point estimates, variance, degree measures, and out-of-equilibrium data. Sociological Methodology, 39(1), 73–116. doi:10.1111/j.1467-9531.2009.01216.x
   PubMed Web of Science ®Google Scholar
• WHO. (n.d.). Hepatitis C fact sheet N°164. Retrieved August 14, 2015, from http://www.who.int/mediacentre/factsheets/fs164/en/
   Google Scholar